AMMECR1LP1

Across TCGA pan-cancer cohorts, AMMECR1LP1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated AMMECR1LP1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher AMMECR1LP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated AMMECR1LP1 expression acts as an unfavorable survival marker, although some lineages such as ACC and KICH show a favorable association.

LUAD, KIRP, and ACC are the cancer types where AMMECR1LP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.351	0.679	<.001	129	view →
KIRP	DFS	Tertile	II,III,IV	0.178	0.701	.002	42	view →
ACC	DFS	Median	III,IV	0.529	0.095	.002	35	view →
OV	OS	Tertile	IV	0.431	0.794	.003	30	view →
THCA	OS	Tertile	All	0.698	0.937	.006	21	view →
KICH	OS	Tertile	All	1.000	0.881	.027	16	view →
PAAD	DFS	Tertile	II,III,IV	0.241	0.488	.037	9	view →
KIRC	OS	Tertile	All	0.753	0.609	.044	9	view →
LIHC	OS	Tertile	III,IV	0.118	0.615	.003	9	view →
LAML	DFS	Quartile	All	0.230	0.442	.035	4	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

AMMECR1LP1–LUAD (DFS)

Open the LUAD breakdown →